We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+8.59%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
+$215M
(+18%)
Cap. Flow
+$157M
Cap. Flow
% of AUM
11.32%
Top 10 Holdings %
Top 10 Hldgs %
5.83%
Holding
2,769
New
981
Increased
606
Reduced
427
Closed
745
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$10.4M |
| 2 |
Visa
V
|
+$10.1M |
| 3 |
CME Group
CME
|
+$7.29M |
| 4 |
Citigroup
C
|
+$6.84M |
| 5 |
Procter & Gamble
PG
|
+$5.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$14.9M |
| 2 |
Microsoft
MSFT
|
+$11.7M |
| 3 |
Chevron
CVX
|
+$5.52M |
| 4 |
Super Micro Computer
SMCI
|
+$5.44M |
| 5 |
Deckers Outdoor
DECK
|
+$5.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.57% |
| 2 | Industrials | 14.16% |
| 3 | Healthcare | 13.54% |
| 4 | Financials | 13.19% |
| 5 | Consumer Discretionary | 11.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXG
1701
Solowin Holdings
AXG
$583M
| $47.5K | ﹤0.01% |
+16,199
| New | +$45.3K |
|
1702
Citius Pharmaceuticals
CTXR
$13.7M
| $46.7K | ﹤0.01% |
+3,730
| New | +$62.8K |
|
1703
Data Storage Corp
DTST
$7.41M
| $46.1K | ﹤0.01% |
+12,221
| New | +$57K |
|
1704
NGL Energy Partners
NGL
$1.87B
| $45.8K | ﹤0.01% |
+10,174
| New | +$45.6K |
|
1705
Nektar Therapeutics
NKTR
$2.39B
| $45.7K | ﹤0.01% |
+2,345
| New | +$44.7K |
|
1706
Quantum Computing Inc
QUBT
$1.74B
| $45.7K | ﹤0.01% |
+69,999
| New | +$44.8K |
|
1707
CBAK Energy Technology Ltd
CBAT
$43.6M
| $45.5K | ﹤0.01% |
+36,400
| New | +$40.8K |
|
1708
Fathom Holdings
FTHM
$28.5M
| $45.3K | ﹤0.01% |
17,493
-1,342
| -7% | -$3.13K |
|
1709
Ovid Therapeutics
OVID
$440M
| $45.1K | ﹤0.01% |
38,230
+12,076
| +46% | +$12.6K |
|
|
GRTS
1710
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $45K | ﹤0.01% |
77,545
+67,347
| +660% | +$37.7K |
|
1711
Werewolf Therapeutics
HOWL
$21.8M
| $45K | ﹤0.01% |
+21,209
| New | +$48.2K |
|
1712
CEMIG Preferred Shares
CIG
$6.21B
| $44.7K | ﹤0.01% |
+21,679
| New | +$43.2K |
|
1713
SKYX Platforms
SKYX
$155M
| $44.6K | ﹤0.01% |
+52,536
| New | +$49.4K |
|
|
GBIO
1714
DELISTED
Generation Bio
GBIO
| $44.3K | ﹤0.01% |
1,792
-11,480
| -86% | -$304K |
|
1715
Beamr Imaging
BMR
$18.9M
| $43.5K | ﹤0.01% |
11,236
-14,422
| -56% | -$60.2K |
|
|
YSG
1716
Yatsen Holding
YSG
$322M
| $43.3K | ﹤0.01% |
+12,701
| New | +$43.9K |
|
1717
Upland Software
UPLD
$14.4M
| $43.1K | ﹤0.01% |
+1,732
| New | +$39.9K |
|
1718
CareCloud
CCLD
$100M
| $42.3K | ﹤0.01% |
+16,012
| New | +$38.3K |
|
|
AKYA
1719
DELISTED
Akoya BioSciences
AKYA
| $41.8K | ﹤0.01% |
15,380
-3,604
| -19% | -$8.8K |
|
|
NIU
1720
Niu Technologies
NIU
$208M
| $41.8K | ﹤0.01% |
+18,155
| New | +$35.1K |
|
|
KRON
1721
DELISTED
Kronos Bio
KRON
| $41.5K | ﹤0.01% |
41,466
-8,445
| -17% | -$9.35K |
|
|
TOUR
1722
Tuniu
TOUR
$56.9M
| $41.2K | ﹤0.01% |
2,899
+1,800
| +164% | +$15.7K |
|
1723
ProKidney
PROK
$316M
| $40.8K | ﹤0.01% |
+21,267
| New | +$48.3K |
|
|
CKPT
1724
DELISTED
Checkpoint Therapeutics
CKPT
| $40.4K | ﹤0.01% |
18,033
+2,428
| +16% | +$5.6K |
|
|
KZR
1725
DELISTED
Kezar Life Sciences
KZR
| $40.3K | ﹤0.01% |
5,215
+3,751
| +256% | +$22.6K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q3 2024 Portfolio in Review
As of Q3 2024, XTX Topco held 2,769 positions worth $1.38B, up 18% from $1.17B the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.
XTX Topco deployed $157M of net new capital in Q3 2024, opening 981 new positions and adding to 606 existing holdings. Its largest new stake was Netflix: 155,440 shares worth $11M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $5.16M trimmed.
- XTX Topco's largest Q3 2024 buy was Netflix: 155,440 shares worth $11M.
- XTX Topco added most to Visa in Q3 2024, an estimated $10.1M increase.
- XTX Topco's biggest Q3 2024 reduction was Meta Platforms (Facebook), cutting an estimated $5.16M.
- XTX Topco fully exited Apple in Q3 2024, selling an estimated $14.9M.
- XTX Topco's ten largest holdings make up 5.8% of its $1.38B portfolio in Q3 2024.
- XTX Topco opened 981 new positions and closed 745 in Q3 2024.
- XTX Topco's portfolio value rose 18% quarter-over-quarter to $1.38B.
Based on XTX Topco's 13F filing for Q3 2024, filed 14 Nov 2024.